| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |